FDA approves Teva's fentanyl transdermal system patches

NORTH WALES, Pa The Food and Drug Administration has approved Teva Pharmaceuticals’ fentanyl transdermal system, CII, Teva announced Thursday.

The drug is available as a patch with dosages of 25 micrograms, 50 micrograms, 75 micrograms and 100 micrograms in cartons containing five patches. It is a generic equivalent to Johnson & Johnson’s Duragesic Transdermal System. Mylan also markets a generic version of the patches.

“Our customers count on Teva for a continuous supply of new generic products,” Teva vice president for sales and marketing John Denman said. “With the launch of fentanyl transdermal system, we add another quality product to our broad line of affordable generic pharmaceuticals.”